The findings suggest that ITGB3-KD enhances the radiosensitivity of osteosarcoma cells by promoting osteogenic differentiation and apoptosis via activation of the JNK/c-JUN/RUNX2 signaling pathway. Here, RUNX2 is linked to osteosarcoma.